{"id":"https://genegraph.clinicalgenome.org/r/88dbba58-3daf-4937-b2fb-15bdeac41fc0v1.0","type":"EvidenceStrengthAssertion","dc:description":"*IFT81* was first reported in relation to autosomal recessive short-rib thoracic dysplasia 19 with or without polydactyly in 2016 (Duran et al., PMID: 27666822). Per criteria outlined by the ClinGen Lumping and Splitting guidelines, we found no differences in molecular mechanism, inheritance pattern or phenotypic variability. Therefore, a single disease entity, short-rib thoracic dysplasia with or without polydactyly, was curated. Seven variants (missense, nonsense, frameshift, intragenic duplication, intragenic deletion) that have been reported in 5 probands in 3 publications (PMIDs: 27666822, 27666822, 30080953) are included in this curation. The mechanism of pathogenicity is unclear. This gene-disease relationship is also supported by experimental evidence of biochemical function, with roles in the Intraflagellar Transport complex, ciliogenesis, and Hedgehog signalling (PMIDs: 22118932, 23990561, 27666822). In summary, there is moderate evidence supporting the relationship between *IFT81* and autosomal recessive short-rib thoracic dysplasia 19. This classification was approved by the ClinGen Skeletal Disorders GCEP on the meeting date March 5, 2025 (SOP Version 11).\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/88dbba58-3daf-4937-b2fb-15bdeac41fc0","GCISnapshot":"https://genegraph.clinicalgenome.org/r/eb2fbc39-acf0-4c60-904a-d712171f601d","calculatedEvidenceStrength":"Moderate","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/eb2fbc39-acf0-4c60-904a-d712171f601d_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10065","date":"2025-06-26T14:41:42.281Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/eb2fbc39-acf0-4c60-904a-d712171f601d_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10065","date":"2025-03-05T17:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eb2fbc39-acf0-4c60-904a-d712171f601d_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1bda84bb-636d-45a4-959a-f0923b319b50_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/380756dd-8960-4319-9023-a4f5599dc011","type":"EvidenceLine","dc:description":"Upgraded by 0.5 points for informative radiographs (Figure 1).","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/380756dd-8960-4319-9023-a4f5599dc011_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Cultured cells from R98-443A were used to assess the effect of variants on IFT81 RNA and protein levels. Western blot analysis of IFT81 showed near complete loss of IFT81 in mutant cells compared to control cells, demonstrating a significant loss of IFT81, more than could be accounted for by the presence of a null allele. These findings suggest that the missense variant destabilized IFT81. ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/380756dd-8960-4319-9023-a4f5599dc011_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666822","allele":{"id":"https://genegraph.clinicalgenome.org/r/150352db-b9ff-436a-a01b-da3ac8bb1b33","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014055.4(IFT81):c.87G>C (p.Leu29Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6782986"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/0f179251-a3f2-4251-be27-834503bf7e52","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0f179251-a3f2-4251-be27-834503bf7e52_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666822","allele":{"id":"https://genegraph.clinicalgenome.org/r/b684c126-060c-4efa-ba70-60d52c137374","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014055.4(IFT81):c.1534C>T (p.Arg512Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6783390"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/1bda84bb-636d-45a4-959a-f0923b319b50","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666822","rdfs:label":"Duran R98-443","ageType":"AgeAtOnset","ageUnit":"Days","ageValue":1,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/b684c126-060c-4efa-ba70-60d52c137374"},{"id":"https://genegraph.clinicalgenome.org/r/150352db-b9ff-436a-a01b-da3ac8bb1b33"}],"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Bowing of the mesomelic segment of the lower extremities, dimples over the lateral knees","phenotypes":["obo:HP_0000954","obo:HP_0001169","obo:HP_0005280","obo:HP_0000269","obo:HP_0008905","obo:HP_0000773","obo:HP_0100818","obo:HP_0004482","obo:HP_0000343","obo:HP_0001252","obo:HP_0001769","obo:HP_0004467","obo:HP_0009381","obo:HP_0005011","obo:HP_0000268","obo:HP_0000520","obo:HP_0000774"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/0f179251-a3f2-4251-be27-834503bf7e52_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/380756dd-8960-4319-9023-a4f5599dc011_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/74442680-1a70-4abb-9726-9e74d501d899_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9b24462d-2785-4415-af29-fd513be76af3","type":"EvidenceLine","dc:description":"Upgraded by 0.5 points for informative radiographs (Figure 2).","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9b24462d-2785-4415-af29-fd513be76af3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32783357","allele":{"id":"https://genegraph.clinicalgenome.org/r/d2695332-86aa-4c1b-ac6a-2bd7ba41634f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000012.12:g.110192709_110192712del","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6783396"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/7fcf283f-674e-4af0-af7e-622afffb98d1","type":"EvidenceLine","dc:description":"Downgraded by 1.0 point because the variant is predicted to escape nonsense-mediated decay.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7fcf283f-674e-4af0-af7e-622afffb98d1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32783357","allele":{"id":"https://genegraph.clinicalgenome.org/r/3cdc3ffe-a4c0-428e-a4d1-0c7cc8c090c3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014055.4(IFT81):c.1934_1937delinsGAAG (p.Leu645Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2695217362"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/74442680-1a70-4abb-9726-9e74d501d899","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32783357","rdfs:label":"Ashraf Case","ageType":"AgeAtReport","ageUnit":"Years","ageValue":2,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/3cdc3ffe-a4c0-428e-a4d1-0c7cc8c090c3"},{"id":"https://genegraph.clinicalgenome.org/r/d2695332-86aa-4c1b-ac6a-2bd7ba41634f"}],"detectionMethod":"Trio exome sequencing","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Proximal fusion of the metacarpals of the ring and middle finger, accessory metacarpal between the ring and little fingers, hindfoot valgus","phenotypes":["obo:HP_0001696","obo:HP_0001561","obo:HP_0000256","obo:HP_0000774","obo:HP_0003026","obo:HP_0000268","obo:HP_0000054","obo:HP_0034374","obo:HP_0030264","obo:HP_0005565","obo:HP_0001655","obo:HP_0001256","obo:HP_0000750","obo:HP_0000045","obo:HP_0025023","obo:HP_0004719","obo:HP_0004467","obo:HP_0004442"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/7fcf283f-674e-4af0-af7e-622afffb98d1_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/9b24462d-2785-4415-af29-fd513be76af3_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/ec167edd-461f-47b2-9b36-9b1c7a044c35_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6a54fdcb-25d8-427a-878f-9253d8d11937","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6a54fdcb-25d8-427a-878f-9253d8d11937_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666822","allele":{"id":"https://genegraph.clinicalgenome.org/r/d02db74c-01f7-4cac-a719-282110eb4f4c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014055.4(IFT81):c.785T>G (p.Leu262Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA386910857"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/558b36f5-659a-4780-a5e9-31d473c747b5","type":"EvidenceLine","dc:description":"Upgraded by 0.5 points for informative radiographs (Figure 1).","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/558b36f5-659a-4780-a5e9-31d473c747b5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666822","allele":{"id":"https://genegraph.clinicalgenome.org/r/a359df4c-5e99-4104-a6b7-c293990299a7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014055.4(IFT81):c.1303_1305del (p.Leu435del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA481849086"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ec167edd-461f-47b2-9b36-9b1c7a044c35","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666822","rdfs:label":"Duran R13-147A","ageType":"AgeAtDeath","ageUnit":"Days","allele":[{"id":"https://genegraph.clinicalgenome.org/r/a359df4c-5e99-4104-a6b7-c293990299a7"},{"id":"https://genegraph.clinicalgenome.org/r/d02db74c-01f7-4cac-a719-282110eb4f4c"}],"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Deceased of respiratory failure minutes after birth","phenotypes":["obo:HP_0012368","obo:HP_0000269","obo:HP_0004482","obo:HP_0001159","obo:HP_0001252","obo:HP_0010306","obo:HP_0008730","obo:HP_0000268","obo:HP_0011220","obo:HP_0001829","obo:HP_0001539","obo:HP_0001629","obo:HP_0011800","obo:HP_0001161","obo:HP_0000369","obo:HP_0002983","obo:HP_0004971","obo:HP_0002878"],"secondTestingMethod":"Sanger sequencing","sex":"Intersex","variant":[{"id":"https://genegraph.clinicalgenome.org/r/558b36f5-659a-4780-a5e9-31d473c747b5_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/6a54fdcb-25d8-427a-878f-9253d8d11937_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/2f3633f4-287b-48d8-905d-6775ae9d4b2a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/752f8910-1496-428f-b1ad-37fe38f716b4","type":"EvidenceLine","dc:description":"One point was subtracted from each variant because Western blot indicated presence of a shorter isoform unaffected by the duplication. 0.5 points added for informative radiographs, 0.5 points subtracted for homozygosity.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/752f8910-1496-428f-b1ad-37fe38f716b4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30080953","allele":{"id":"https://genegraph.clinicalgenome.org/r/100912be-2c9f-40e7-ab67-e9cf61826de9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"GRCh38 12q24.11(chr12:110138661-110155546)x3"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/2f3633f4-287b-48d8-905d-6775ae9d4b2a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30080953","rdfs:label":"Pettersson Case","ageType":"AgeAtReport","ageUnit":"Years","ageValue":8,"allele":{"id":"https://genegraph.clinicalgenome.org/r/100912be-2c9f-40e7-ab67-e9cf61826de9"},"detectionMethod":"Genome sequencing","phenotypes":["obo:HP_0009824","obo:HP_0001655","obo:HP_0002098","obo:HP_0001156","obo:HP_0000774","obo:HP_0002779","obo:HP_0004322"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/752f8910-1496-428f-b1ad-37fe38f716b4_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":6.5},{"id":"https://genegraph.clinicalgenome.org/r/eb2fbc39-acf0-4c60-904a-d712171f601d_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eb2fbc39-acf0-4c60-904a-d712171f601d_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/47928f96-c0ab-499c-a08a-891aca78f263","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/43d66696-d980-4f12-b84d-bcbf721b5574","type":"Finding","dc:description":"Intact cilia are necessary for Hedgehog signaling. To determine whether Hedgehog (Hh) signaling was affected in mutant cells, protein levels of GLI3 were analyzed. GLI3 is a bi-functional transcription factor that is activated through the Hh intracellular cascade. When Hh is absent, GLI3 is proteolytically processed and acts as a transcriptional repressor (R) of Hh downstream targets. Conversely, binding of Hh ligands to the Patched receptor activates Smooothened in the cilia, leading to repression of the processing of GLI3, increased full-length (FL) GLI3 transcriptional activator and increased transcription of Hh downstream genes. In the normal state, the GLI3 FL/R ratio determines the transcriptional output of Hh signaling. In chondrocytes from a patient with IFT81 variants (c.87G>C, p.Leu29Phe; c.1534C>T, p.Arg512*) there was an increased FL/R ratio at baseline (Fig. 3G,H) that was exaggerated in response to the Hh agonist SAG (Fig. 3G,H), implying IFT81 mutant cells have permanently dysregulated Hh signaling. Transfection of the cells with IFT81 rescued the GLI3 FL levels and partially rescued the FL/R ratio in mutant cells due to the simultaneous decrease of GLI3FL and R forms. These findings suggest that IFT81 variants altered hedgehog signaling. Skeletal ciliopathy phenotypes are thought to result from imbalances in the hedgehog signaling pathway that normally occur in functional cilia in chondrocytes (PMID: 25506500).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27666822","rdfs:label":"Western blot","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f2b164cb-be6d-4db7-8b2d-a4f304ebfea3","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aa81352e-10aa-451e-ab60-0de941fca322","type":"Finding","dc:description":"Intraflagellar transport (IFT) of ciliary precursors such as tubulin from the cytoplasm to the ciliary tip is involved in the construction of the cilium. The two core IFT proteins IFT74 and IFT81 were found to form a tubulin-binding module. Knockdown of IFT81 and rescue experiments with point mutants showed that tubulin binding by IFT81 was required for ciliogenesis in human cells. Ciliary dysfunction results in ciliopathy disorders. Short-rib thoracic dysplasia 19 with or without polydactyly is a skeletal ciliopathy.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23990561","rdfs:label":"IFT81 knockdown and rescue","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/6a5d0c4e-ec4c-462d-8369-0ee6c8e8c5e6","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d6c6528e-abba-40c9-a311-750bfe1e891b","type":"Finding","dc:description":"The IFT complex plays a role in Intraflagellar Transport (IFT). IFT81 is a core protein of the IFT-B complex. IFT80 is an associated subunit of the IFT-B complex. IFT80 has been curated as Definitive for asphyxiating thoracic dystrophy 2 by the ClinGen Skeletal Disorders GCEP. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22118932","rdfs:label":"Review article","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1.5}],"evidenceStrength":"Moderate","sequence":10691,"specifiedBy":"GeneValidityCriteria11","strengthScore":8,"subject":{"id":"https://genegraph.clinicalgenome.org/r/Nn81yvUky2k","type":"GeneValidityProposition","disease":"obo:MONDO_0033485","gene":"hgnc:14313","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_eb2fbc39-acf0-4c60-904a-d712171f601d-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}